AT
Allinaire Therapeutics Inc.
SEC filingOther · Cleveland, OH
Amount raised$700Ksold at filing
Total offering$700K
Investors in the raise2count reported to the SEC
FiledApr 14, 2026first sale Jan 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Douglas W.P. HayExecutive Officer, Director
Satish W.P. JindalDirector
Arthur W.P. BertelsonDirector
Samantha W.P. GintherDirector
Executive officers, directors and promoters as listed on the Form D.